Long-term Follow-up of COPD with OSAS Treated at Home for SARS-COV 2 Infection while Receiving BD/F/G - A Case Study

S. Maria Delle Grazie Hospital, Via Domitiana, 80078 Localit�?�?�?�?�?�?�?�?�?�?�?�?�?�?�?�?�?�?�?�?�?�?�?�?�?�?�?�?�?�?�? La Schiana, Pozzuoli, Napoli, Italy

Posters & Accepted Abstracts: Health Sci J

Abstract:

We report a case of a COPD+OSAS patient who developed COVID-19 disease 6 months after starting add-on therapy with BD/F/G. Both COPD and OSAS were under control with no exacerbation at the time of SARS-CoV2 infection. Although the bilateral interstitial pneumonia due to COVID-19, the patient was treated at home without complications, with improvement of the chest CT scan after Antibiotic and Methylprednisolone treatment and low- flow oxygen therapy. He regularly performed inhalation therapy without CPAP. Lung function parameters 3 months after healing reached normal levels as before COVID-19 development. A long-term follow-up after 24 months from BD/F/G introduction showed a normal lung function and well controlled COPD, no exacerbations or corticosteroid bursts.
References
1. Halpin DMG, Faner R, Sibila O, Badia JR, Agusti A (2020) Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med 8: 436-438.
2. Beltramo G, Cottenet J, Mariet AS, Georges M, Piroth L, et al. (2021) Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study. Eur Respir J pp: 2004474.

HTML